Cowen and Company’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,550,000	Closed	-$4.45M	–	638
2024 Q1	$4.45M	Buy	+1,550,000	New	+$4.45M	0.17%	62